Teva Neuroscience, Inc. · Kansas City, MO United States
| 901 E. 104th St., Ste. 900 | Phone: 816-508-5000 |
| Kansas City, MO | Fax: 816-508-5016 |
| 64131 | Toll Free: 800-221-4026 |
| United States | 
Map This Company |
Teva Neuroscience, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Teva Neuroscience never deviates from its focus on developing and marketing drugs for neurological disorders. The company's primary product is Copaxone, an injection drug designed to reduce relapses in patients with relapsing-remitting multiple sclerosis. Teva Neuroscience also distributes Azilect, a treatment for Parkinson's disease, and the company is conducting research into other neurological disorders. Its products are marketed through direct sales representatives and distributors in North America. In addition, the company has established several patient education and advocacy programs for multiple sclerosis patients. Teva Neuroscience is a subsidiary of Israeli drugmaker
Teva Neuroscience, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiarySingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 450 |
Executives
36 executives listed for Teva Neuroscience, Inc.'s Kansas City, MO location.
| President and CEO | Larry Downey | |
|---|---|---|
| Senior Director Finance and Planning | Stefan Feltans | |
| VP Professional Education and Scientific Communications | Marty Berndt |